Drug Type Recombinant polypeptide |
Synonyms PACAP, Pituitary adenylate cyclase activating polypeptide, PACAP 1-27 + [3] |
Target |
Action stimulants |
Mechanism AC stimulants(Adenylate cyclases stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | - | - | |
Asthma | Phase 1 | - | - | |
Non-Small Cell Lung Cancer | Preclinical | - | - | |
Non-Small Cell Lung Cancer | Preclinical | - | - | |
Cardiotoxicity drug-induced | Discovery | United States | 15 Jul 2017 | |
Stroke | Discovery | United States | 15 Nov 2006 |
Not Applicable | - | jeahvvaozi(jojpituhlc) = nlytzafslb nsrtqmjmqp (tbfdwmgiqw ) | - | 04 Apr 2023 | |||
jeahvvaozi(jojpituhlc) = fhjsjugokl nsrtqmjmqp (tbfdwmgiqw ) | |||||||
Not Applicable | Inflammation PACAP receptors | - | agrukndynn(yslkibhlti) = gfwdhlcqvy gxfciqtxos (rvzsyiopzt, 0.5) | Positive | 16 Sep 2014 | ||
LPS | ovidpjffqq(zohcxjhwwg) = iensvfeceg rcrslibnou (qbanelzpzo ) View more | ||||||
Not Applicable | - | - | (Restraint stress) | lzsbkpsukx(sisfshjldf) = dwgqiabfgm jvaonwcuob (brsojsynss ) | - | 05 Nov 2013 | |
lzsbkpsukx(sisfshjldf) = qfjqfqspei jvaonwcuob (brsojsynss ) | |||||||
Not Applicable | 4 | (Patients with congenital nephrotic syndrome (CNS)) | stwajtdokb(hxsdxivtti) = increased platelet count qcjdpqpkgu (keqbrfrgrf ) View more | Positive | 30 Oct 2012 | ||
Not Applicable | - | (Control (no treatment)) | caqyddrfko(zpsosyucrp) = chsgoutqpy ggyvfedpyq (attecplqid ) | Positive | 16 Nov 2010 | ||
caqyddrfko(zpsosyucrp) = qhbnivfhbr ggyvfedpyq (attecplqid ) |